Hemorheological Alterations in Patients with Heart Failure with Reduced Ejection Fraction Treated by Resveratrol.
Roland GalDora PrakschPeter KenyeresMiklos RabaiKalman TothRobert HalmosiTamas HabonPublished in: Cardiovascular therapeutics (2020)
These findings indicate that resveratrol can significantly reduce red blood cell aggregation, which may positively influence microcirculation, which may contribute to the improvement of tissue perfusion and oxygen supply in heart failure.